95 related articles for article (PubMed ID: 35897761)
41. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
42. Full Neurovascular Sparing Extraperitoneal Robotic Radical Prostatectomy: Our Experience with PERUSIA Technique.
Cochetti G; Boni A; Barillaro F; Pohja S; Cirocchi R; Mearini E
J Endourol; 2017 Jan; 31(1):32-37. PubMed ID: 27824258
[TBL] [Abstract][Full Text] [Related]
43. Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.
Munkley J; Vodak D; Livermore KE; James K; Wilson BT; Knight B; Mccullagh P; Mcgrath J; Crundwell M; Harries LW; Leung HY; Robson CN; Mills IG; Rajan P; Elliott DJ
EBioMedicine; 2016 Jun; 8():103-116. PubMed ID: 27428423
[TBL] [Abstract][Full Text] [Related]
44. The Molecular Taxonomy of Primary Prostate Cancer.
Cancer Genome Atlas Research Network
Cell; 2015 Nov; 163(4):1011-25. PubMed ID: 26544944
[TBL] [Abstract][Full Text] [Related]
45. Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer.
Niu Z; Wang M; Zhou L; Yao L; Liao Q; Zhao Y
Sci Rep; 2015 Nov; 5():16067. PubMed ID: 26530532
[TBL] [Abstract][Full Text] [Related]
46. The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.
Munkley J; Oltean S; Vodák D; Wilson BT; Livermore KE; Zhou Y; Star E; Floros VI; Johannessen B; Knight B; McCullagh P; McGrath J; Crundwell M; Skotheim RI; Robson CN; Leung HY; Harries LW; Rajan P; Mills IG; Elliott DJ
Oncotarget; 2015 Oct; 6(33):34358-74. PubMed ID: 26452038
[TBL] [Abstract][Full Text] [Related]
47. Glycosylation in cancer: mechanisms and clinical implications.
Pinho SS; Reis CA
Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
[TBL] [Abstract][Full Text] [Related]
48. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.
Morgan MA; Lawrence TS
Clin Cancer Res; 2015 Jul; 21(13):2898-904. PubMed ID: 26133775
[TBL] [Abstract][Full Text] [Related]
49. Targeting the endoplasmic reticulum mediates radiation sensitivity in colorectal cancer.
Drake TM; Ritchie JE; Kanthou C; Staves JJ; Narramore R; Wyld L
Exp Mol Pathol; 2015 Jun; 98(3):532-9. PubMed ID: 25825019
[TBL] [Abstract][Full Text] [Related]
50. Reactive oxygen species as mediator of tumor radiosensitivity.
Dayal R; Singh A; Pandey A; Mishra KP
J Cancer Res Ther; 2014; 10(4):811-8. PubMed ID: 25579513
[TBL] [Abstract][Full Text] [Related]
51. Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes.
Barfeld SJ; East P; Zuber V; Mills IG
BMC Med Genomics; 2014 Dec; 7():513. PubMed ID: 25551447
[TBL] [Abstract][Full Text] [Related]
52. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
Itkonen HM; Engedal N; Babaie E; Luhr M; Guldvik IJ; Minner S; Hohloch J; Tsourlakis MC; Schlomm T; Mills IG
Oncogene; 2015 Jul; 34(28):3744-50. PubMed ID: 25241896
[TBL] [Abstract][Full Text] [Related]
53. Nuclear receptor LRH-1/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution.
Mamrosh JL; Lee JM; Wagner M; Stambrook PJ; Whitby RJ; Sifers RN; Wu SP; Tsai MJ; Demayo FJ; Moore DD
Elife; 2014 Apr; 3():e01694. PubMed ID: 24737860
[TBL] [Abstract][Full Text] [Related]
54. The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response.
Nagelkerke A; Bussink J; van der Kogel AJ; Sweep FC; Span PN
Radiother Oncol; 2013 Sep; 108(3):415-21. PubMed ID: 23891100
[TBL] [Abstract][Full Text] [Related]
55. PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells.
Chatterjee P; Choudhary GS; Sharma A; Singh K; Heston WD; Ciezki J; Klein EA; Almasan A
PLoS One; 2013; 8(4):e60408. PubMed ID: 23565244
[TBL] [Abstract][Full Text] [Related]
56. The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS; Wu YM; Robinson DR; Cao X; Dhanasekaran SM; Khan AP; Quist MJ; Jing X; Lonigro RJ; Brenner JC; Asangani IA; Ateeq B; Chun SY; Siddiqui J; Sam L; Anstett M; Mehra R; Prensner JR; Palanisamy N; Ryslik GA; Vandin F; Raphael BJ; Kunju LP; Rhodes DR; Pienta KJ; Chinnaiyan AM; Tomlins SA
Nature; 2012 Jul; 487(7406):239-43. PubMed ID: 22722839
[TBL] [Abstract][Full Text] [Related]
57. The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.
Guerriero CJ; Brodsky JL
Physiol Rev; 2012 Apr; 92(2):537-76. PubMed ID: 22535891
[TBL] [Abstract][Full Text] [Related]
58. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2.
Jung YH; Lim EJ; Heo J; Kwon TK; Kim YH
Int J Oncol; 2012 Jun; 40(6):1941-8. PubMed ID: 22426894
[TBL] [Abstract][Full Text] [Related]
59. Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells.
Kimata Y; Kohno K
Curr Opin Cell Biol; 2011 Apr; 23(2):135-42. PubMed ID: 21093243
[TBL] [Abstract][Full Text] [Related]
60. Integrative genomic profiling of human prostate cancer.
Taylor BS; Schultz N; Hieronymus H; Gopalan A; Xiao Y; Carver BS; Arora VK; Kaushik P; Cerami E; Reva B; Antipin Y; Mitsiades N; Landers T; Dolgalev I; Major JE; Wilson M; Socci ND; Lash AE; Heguy A; Eastham JA; Scher HI; Reuter VE; Scardino PT; Sander C; Sawyers CL; Gerald WL
Cancer Cell; 2010 Jul; 18(1):11-22. PubMed ID: 20579941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
